Tesamorelin

Price range: £28.00 through £42.50

Tesamorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH) studied for its role in stimulating endogenous growth hormone and influencing IGF-1 pathways. Clinical research has examined its effects on visceral adipose tissue and metabolic biomarkers. Intended for research purposes only, not for human consumption.  In research settings, Tesamorelin is mainly investigated for its potential effects on growth hormone signalling, body composition, and metabolic function.

Category:
Tags: ,

Description

Tesamorelin

Research Grade Peptide – Laboratory Use Only

Tesamorelin supplied by D&L Peptides is a high-purity synthetic peptide provided exclusively for laboratory research purposes. It is supplied as a research material and is not authorised, approved, or intended for human or veterinary use, clinical application, diagnostic procedures, or therapeutic purposes.


Scientific Context (Research Classification Only)

Tesamorelin is described in scientific literature as a synthetic analogue of growth hormone-releasing hormone (GHRH). In experimental and pre-clinical research models, peptides of this classification are studied for their role in:

  • Hypothalamic–pituitary signalling pathways

  • Regulation of growth hormone secretion in experimental systems

  • Endocrine feedback mechanisms

  • Hormone–receptor interaction and signal transduction

All references to biological activity are provided solely for academic and scientific context and do not imply safety, efficacy, or suitability for any non-research application.


Research Classification

  • Peptide Type: Synthetic GHRH analogue (research classification only)

  • Intended Use: Laboratory research only

  • Regulatory Status: Not authorised or approved by the MHRA or any other regulatory authority

D&L Peptides makes no representations or claims regarding biological outcomes, performance, or safety outside of lawful laboratory research.


Quality & Analytical Verification

Each batch of Tesamorelin supplied by D&L Peptides undergoes analytical testing to verify identity, purity, and composition for research use.

  • Certificates of Analysis (COAs) are available on request

  • COAs correspond directly to the supplied products

Independent analytical testing does not constitute regulatory approval or authorisation for human or veterinary use.


Product Characteristics

  • Form: Lyophilised solid

  • Purity: ≥99% (batch-specific)

  • Presentation: Sealed research vial

  • Classification: Research Use Only (RUO)

Physical appearance may vary between batches due to the nature of the lyophilisation process and does not indicate nonconformity.


Handling & Storage Notice

This product is supplied strictly as a laboratory research material.

All handling, preparation, storage, and disposal must be conducted:

  • By appropriately trained and qualified personnel

  • Within controlled laboratory environments

  • In accordance with institutional protocols and applicable laws and regulations

D&L Peptides does not provide instructions, recommendations, or guidance regarding preparation methods, concentrations, solvents, or downstream use.


Regulatory & Legal Notice

This product:

  • Is not a medicinal product under the Human Medicines Regulations 2012

  • Is not authorised or approved by the MHRA

  • Is not intended for human or veterinary use

  • Is not for clinical, diagnostic, or therapeutic application

By purchasing this product, the buyer represents and warrants that it will be used solely for lawful laboratory research purposes and in full compliance with all applicable regulatory and institutional requirements.

D&L Peptides accepts no liability for use outside of permitted research applications.


Important Statement

For Laboratory Research Use Only.
Not for Human or Veterinary Use.

Additional information

Weight

5 mg, 10 mg

Related products

Verified by MonsterInsights